Y-mAbs Therapeutics, Inc.·4

Dec 4, 6:00 PM ET

Rajah Vignesh 4

4 · Y-mAbs Therapeutics, Inc. · Filed Dec 4, 2020

Insider Transaction Report

Form 4
Period: 2020-11-17
Rajah Vignesh
SVP and CMO
Transactions
  • Purchase

    Common Stock

    2020-12-02$51.03/sh+233$11,8901,697 total(indirect: By Children)
  • Purchase

    Common Stock

    2020-11-17$45.74/sh+1,464$66,9631,464 total(indirect: By Spouse)
Footnotes (2)
  • [F1]Reporting Person may be deemed to have a pecuniary interest in the securities due to family relationship.
  • [F2]Reporting Person disclaims beneficial ownership of the securities reported and this report shall not be deemed an admission that Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act, as amended, or for any other purpose.

Documents

1 file
  • 4
    a4.xmlPrimary

    4